The government is taking steps to curb use of some long-acting asthma drugs taken by millions, issuing safety restrictions Thursday to lower an uncommon but potentially life-threatening risk that ...

BURLINGTON, Mass.--(BUSINESS WIRE)-- Decision Resources, one of the world’s leading research and advisory firms focusing on pharmaceutical and healthcare issues, finds that patient share of ...

WASHINGTON — Government health advisers recommended restrictions Thursday on some long-acting asthma drugs, although not Advair, a top-selling medication. Outside experts advising the Food and Drug ...

WASHINGTON — Two federal drug officials have concluded that asthma patients risk death if they continue to use four hugely popular asthma drugs: Advair, Symbicort, Serevent and Foradil. But the ...

This article was originally on a blog post platform and may be missing photos, graphics or links. See About archive blog posts. Asthma patients should not take inhalable long-acting beta-agonists such ...

WASHINGTONWASHINGTON — The government is taking steps to curb use of some long-acting asthma drugs taken by millions, issuing safety restrictions Thursday to lower an uncommon but potentially ...

LargePharma_SymbicortAstraZeneca’s Symbicort, the second-to-market ICS/LABA combo behind GlaxoSmithKline’s Advair, faced an uphill battle on its launch in June 2007, squaring off against a firmly ...

GSK’s partnership with Theravance has yielded a pair of promising COPD treatments -- but will they be enough to protect it from Advair’s patent expirations? GSK's COPD drug candidate, Anoro Ellipta, ...

LONDON, May 20 (Reuters) - Patients with asthma prefer AstraZeneca Plc's drug Symbicort to GlaxoSmithKline Plc's Advair, according to results of a clinical study backed by AstraZeneca released on ...

GlaxoSmithKline is shifting its sales force strategy for therapy Advair to stress treatment for chronic obstructive pulmonary disease (COPD), a new report stated. Advair, a long-acting beta2 agonist ...